HRZN Share Price Performance
US$6.38
-2.45 (-27.75%)
6.2% undervalued intrinsic discount
US$6.80
Fair Value
Price US$6.38
AnalystConsensusTarget US$6.80
Fair ValueUS$6.80
Share Pricen/a
Horizon Technology Finance Corporation Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 33 Fair Values set on narratives written by author
HRZN Community Narratives
AN
Fair Value US$6.8 6.2% undervalued intrinsic discount
Venture Debt Demand And Monroe Merger Will Support Fair Long Term Outlook
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Horizon Technology Finance
Venture Debt Demand And Monroe Merger Will Support Fair Long Term Outlook
Catalysts About Horizon Technology Finance Horizon Technology Finance provides venture debt solutions to high growth technology and life sciences companies and seeks to generate attractive returns through a high yielding, primarily floating rate portfolio. What are the underlying business or industry changes driving this perspective?Read more
16
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$6.8
6.2% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
16.64% p.a.
Profit Margin
95.01%
Future PE
3.47x
Price in 2028
US$8.73
Trending Discussion
Recently Updated Narratives
AN
Venture Debt Demand And Monroe Merger Will Support Fair Long Term Outlook
Fair Value: US$6.8 6.2% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Horizon Technology Finance Corporation Key Details
Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
- -0.54
- 100.00%
- -24.19%
- 134.3%
About HRZN
- Founded
- 2008
- Employees
- n/a
- CEO
- Website
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, cleantech and sustainability industries. It seeks to invest in companies in the United States.
